Erythrocytapheresis with Recombinant Human Erythropoietin in Hereditary Hemochromatosis Therapy: A New Alternative
2000
Background and Objectives: The purposes of this study were to evaluate the tolerance, efficacy and safety of isovolemic erythrocytapheresis (EA) in nonanemic patients with hereditar
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
44
References
27
Citations
NaN
KQI